New York · 2025 Regular Session · Bill
S 4587: Relates to prescription labels for mifepristone and misoprostol
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 4587 is a bill introduced in the New York Senate on February 7, 2025. According to its official title, it concerns: Relates to prescription labels for mifepristone and misoprostol. Primary sponsor: Shelley Mayer (Democratic/Working Families). It lists 1 additional sponsor. Most recent recorded action (March 10, 2025): SUBSTITUTED BY A5285.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Sponsors
Sponsors by party (alphabetical): Democratic/Working Families 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shelley Mayer | Primary sponsor | Democratic/Working Families | Senate | 37 |
| Lea Webb | Co-sponsor | Democratic/Working Families | Senate | 52 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- SUBSTITUTED BY A5285
- ORDERED TO THIRD READING CAL.447
- REFERRED TO RULES